• Philippe Abdel-Sayed, Dorian Tornay, Nathalie Hirt-Burri, Anthony de Buys Roessingh, Wassim Raffoul, and Lee Ann Applegate.
• Regenerative Therapy Unit, Lausanne University Hospital, Switzerland; Service of Plastic, Reconstructive & Hand Surgery, Lausanne University Hospital, Switzerland.
• Burns. 2020 Aug 1; 46 (5): 1150-1156.

AbstractChlorhexidine is known to be a potent antiseptic with evidence of a beneficial role in burn care. Nevertheless, several in vitro studies have reported cytotoxicity on cultured cells, while in vivo and clinical data seem to show more controversial results. In the frame of this work, we aimed to evaluate the use of chlorhexidine in burn units worldwide be sending a survey to professionals of the field. We associated survey results to those perspectives reported in the literature to update recommendations for the use of chlorhexidine in specific protocols for burn management. The survey results showed that there is no clear consensus on the use of chlorhexidine regarding the concentrations, the type of excipient and the cleansing after application. Literature searches showed evidence that the skin of premature infants appears to be more sensitive to chlorhexidine that adult skin, with more reported cases of adverse effects. It was also determined that aqueous formulations of chlorhexidine do not appear to be necessarily less efficient than with alcohol as an excipient, and that lower concentrations are as efficient as higher concentrations. In view of this study, we have adjusted our protocols for the use of aqueous formulations at low concentrations and investigated further the role of washing after application in order to standardize the indication of chlorhexidine and minimize the probability of adverse effects.Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

20 keywords...

hide…